FR3008698B1 - Procede pour la production d'un actif pharmaceutique - Google Patents

Procede pour la production d'un actif pharmaceutique

Info

Publication number
FR3008698B1
FR3008698B1 FR1357104A FR1357104A FR3008698B1 FR 3008698 B1 FR3008698 B1 FR 3008698B1 FR 1357104 A FR1357104 A FR 1357104A FR 1357104 A FR1357104 A FR 1357104A FR 3008698 B1 FR3008698 B1 FR 3008698B1
Authority
FR
France
Prior art keywords
production
pharmaceutical active
pharmaceutical
active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1357104A
Other languages
English (en)
Other versions
FR3008698A1 (fr
Inventor
Eric Belot
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NEUROPTIS BIOTECH
Original Assignee
NEUROPTIS BIOTECH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NEUROPTIS BIOTECH filed Critical NEUROPTIS BIOTECH
Priority to FR1357104A priority Critical patent/FR3008698B1/fr
Priority to PCT/EP2014/065538 priority patent/WO2015007896A1/fr
Priority to EP14741611.9A priority patent/EP3022187A1/fr
Priority to JP2016526659A priority patent/JP2016525109A/ja
Publication of FR3008698A1 publication Critical patent/FR3008698A1/fr
Application granted granted Critical
Publication of FR3008698B1 publication Critical patent/FR3008698B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/08—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FR1357104A 2013-07-18 2013-07-18 Procede pour la production d'un actif pharmaceutique Active FR3008698B1 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FR1357104A FR3008698B1 (fr) 2013-07-18 2013-07-18 Procede pour la production d'un actif pharmaceutique
PCT/EP2014/065538 WO2015007896A1 (fr) 2013-07-18 2014-07-18 Procede pour la production d'une 1-(5-halonaphtalene-1-sulfonyl)-1h-hexahydro-1,4-diazepine et composition la comprenant
EP14741611.9A EP3022187A1 (fr) 2013-07-18 2014-07-18 Procede pour la production d'une 1-(5-halonaphtalene-1-sulfonyl)-1h-hexahydro-1,4-diazepine et composition la comprenant
JP2016526659A JP2016525109A (ja) 2013-07-18 2014-07-18 １−（５−ハロナフタレン−１−スルホニル）−１ｈ−ヘキサヒドロ−１，４−ジアゼピンの製造方法及びそれを含む組成物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1357104A FR3008698B1 (fr) 2013-07-18 2013-07-18 Procede pour la production d'un actif pharmaceutique

Publications (2)

Publication Number Publication Date
FR3008698A1 FR3008698A1 (fr) 2015-01-23
FR3008698B1 true FR3008698B1 (fr) 2016-10-28

Family

ID=49998319

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1357104A Active FR3008698B1 (fr) 2013-07-18 2013-07-18 Procede pour la production d'un actif pharmaceutique

Country Status (4)

Country Link
EP (1) EP3022187A1 (fr)
JP (1) JP2016525109A (fr)
FR (1) FR3008698B1 (fr)
WO (1) WO2015007896A1 (fr)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6287581A (ja) * 1985-10-11 1987-04-22 Hokuriku Seiyaku Co Ltd ナフタレンスルホンアミド誘導体
JP2528451B2 (ja) * 1986-07-09 1996-08-28 北陸製薬株式会社 ナフタレンスルホンアミド誘導体
US5798380A (en) * 1996-02-21 1998-08-25 Wisconsin Alumni Research Foundation Cytoskeletal active agents for glaucoma therapy
WO2004069181A2 (fr) * 2003-02-03 2004-08-19 Pharmacia Corporation Compositions d'un agent modulateur de l'aquaporine et d'un agent modulateur de l'humeur aqueuse pour le traitement d'une pression intra-oculaire elevee
US20050222127A1 (en) * 2004-03-30 2005-10-06 Alcon, Inc. Use of Rho kinase inhibitors in the treatment of hearing loss, tinnitus and improving body balance
FR2879100B1 (fr) * 2004-12-09 2007-07-06 Lionel Bueno Compositions pour le traitement des pathologies oculaires de surface et de la retine
US20110039770A1 (en) * 2005-08-05 2011-02-17 Pharmagap Inc. Inhibitors of protein kinase c isoforms and uses thereof

Also Published As

Publication number Publication date
FR3008698A1 (fr) 2015-01-23
WO2015007896A1 (fr) 2015-01-22
JP2016525109A (ja) 2016-08-22
EP3022187A1 (fr) 2016-05-25

Similar Documents

Publication Publication Date Title
FR2991320B1 (fr) Procede de preparation d'amines methylees
MA41200A (fr) Procédé pour la préparation d'un composé diarylthiohydantoïne
FR3001970B1 (fr) Procede de preparation d'acide 2,5-furane dicarboxylique
FR3006800B1 (fr) Procede d'approche d'une plateforme
FR2999572B1 (fr) Procede de production d'acrylate d'alkyle.
FR3007425B1 (fr) Nouveau procede de fabrication d'acide formique
FR2961808B1 (fr) Procede de production de methionine
FR3002080B1 (fr) Procede de fabrication d'un transistor
FR3002079B1 (fr) Procede de fabrication d'un transistor
FR2994178B1 (fr) Procede de preparation d'un acide carboxylique ou d'un aldehyde
FR3028526B1 (fr) Procede de valorisation de biomasse de levure issues de la production d'ethanol
FR3030230B1 (fr) Procede de coloration a partir d'orthodiphenol
FR3002771B1 (fr) Procede de production d'acrylate de 2-propyl heptyle par transesterefication
FR2994973B1 (fr) Procede de production d'acide methacrylique
FR2991612B1 (fr) Procede d'obtention par fonderie d'une piece comportant une portion effilee
FR2968002B1 (fr) Procede pour la production de dibk
FR3014437B1 (fr) Nouveau procede de synthese de l'agomelatine
FR3000968B1 (fr) Procede d'elaboration d'un materiau nanocomposite al/tic
FR3004727B1 (fr) Procede de production d'hydrocarbures
FR2992641B1 (fr) Procede de preparation d'un sel de medicament anti-inflammatoire non steroidien
FR3008698B1 (fr) Procede pour la production d'un actif pharmaceutique
FR3017617B1 (fr) Procede de production d'acide acrylique bio-source
FR2990886B1 (fr) Procede pour la fabrication d'une piece en tole.
FR3015462B1 (fr) Procede et installation pour la production conjointe de composes de l'uranium et d'acide fluorhydrique anhydre.
FR3017878B1 (fr) Procede de production de lactones a partir d'une souche d'aureobasidium pullulans

Legal Events

Date Code Title Description
CA Change of address

Effective date: 20150327

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6